BRAF and thyroid cancer, nonmedullary, 2: DNA methylation levels vary across subtypes: PTC shows the lowest frequency, FTC exhibits a high hyper-/hypomethylation ratio, potentially linked to differential BRAF/RAS mutation burdens [6,24], while ATC displays global hypomethylation with CpG island hypermethylation [25,26].